MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 03 report with the FDA on 1999-02-05 for BARD CONTIGEN IMPLANT 651005 manufactured by C.r. Bard, Inc..
[175305]
Sterile abscess developed at injection site 6 weeks after routine transurethral injection. Drainage procedure for relief of obstructive & irritative voiding systems required. Transurethral unroofing failed and transvaginal incision and drainage were required. Pt currently asymptomatic except for continued urinary incontinence.
Patient Sequence No: 1, Text Type: D, B5
| Report Number | 1018233-1999-00003 |
| MDR Report Key | 209324 |
| Report Source | 03 |
| Date Received | 1999-02-05 |
| Date of Report | 1999-02-05 |
| Date Mfgr Received | 1999-01-14 |
| Date Added to Maude | 1999-02-11 |
| Event Key | 0 |
| Report Source Code | Manufacturer report |
| Manufacturer Link | Y |
| Number of Patients in Event | 0 |
| Adverse Event Flag | 3 |
| Product Problem Flag | 3 |
| Reprocessed and Reused Flag | 0 |
| Health Professional | 3 |
| Initial Report to FDA | 3 |
| Report to FDA | 3 |
| Event Location | 3 |
| Single Use | 3 |
| Previous Use Code | 3 |
| Event Type | 3 |
| Type of Report | 3 |
| Brand Name | BARD CONTIGEN IMPLANT |
| Generic Name | INCONTINENCE IMPLANT |
| Product Code | LMI |
| Date Received | 1999-02-05 |
| Model Number | NA |
| Catalog Number | 651005 |
| Lot Number | UNK |
| ID Number | UNK |
| Operator | OTHER |
| Device Availability | N |
| Device Age | UNKNOWN |
| Device Eval'ed by Mfgr | R |
| Implant Flag | Y |
| Date Removed | A |
| Device Sequence No | 1 |
| Device Event Key | 203140 |
| Manufacturer | C.R. BARD, INC. |
| Manufacturer Address | 8195 INDUSTRIAL BLVD. COVINGTON GA 30014 US |
| Baseline Brand Name | CONTIGEN BARD COLLAGEN IMPLANT |
| Baseline Generic Name | INCONTINENCE IMPLANT |
| Baseline Model No | NA |
| Baseline Catalog No | 651005 |
| Baseline ID | NA |
| Baseline Device Family | BARD CONTIGEN IMPLANT |
| Baseline Shelf Life Contained | Y |
| Baseline Shelf Life [Months] | 36 |
| Baseline PMA Flag | Y |
| Premarket Approval | P9000 |
| Baseline 510K PMN | N |
| Baseline Preamendment | N |
| Baseline Transitional | N |
| 510k Exempt | N |
| Patient Number | Treatment | Outcome | Date |
|---|---|---|---|
| 1 | 0 | 1. Required No Informationntervention | 1999-02-05 |